ACCEL Lite: ESC Congress 2021 Late Breaker: IAMI

In this interview, Laxmi Mehta, MD, FACC, and Ole Frobert, MD, PhD, and discuss the ESC Congress 2021 late breaker IAMI. This study evaluates whether influenza vaccination improves outcomes in patients with recent myocardial infarctions (MI). Influenza vaccine reduced the risk of the primary composite endpoint of all-cause death, MI, and stent thrombosis. Influenza vaccine also reduced two of the three key secondary endpoints: all-cause death and cardiovascular death.

Like what you hear? ACCEL Subscribers enjoy 20+ insider interviews like these every month, with CME/MOC credit and other exclusive benefits. Subscribe today for more, and check out what's new at www.acc.org/ACCEL.




Clinical Topics: Acute Coronary Syndromes, Cardiovascular Care Team, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Stable Ischemic Heart Disease, Vascular Medicine, Interventions and ACS, Interventions and Imaging, Interventions and Vascular Medicine, Angiography, Nuclear Imaging, Chronic Angina

Keywords: ACCELLite, ESC Congress, ESC21, Acute Coronary Syndrome, Coronary Angiography, Coronary Disease, COVID-19, Influenza Vaccines, Influenza, Human, Myocardial Infarction, ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, Risk Factors, Secondary Prevention, Stents, Thrombosis, Vaccination, SARS-CoV-2


< Back to Listings